Pinnacle Associates’s Evolus EOLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$10.3M Buy
1,487,264
+328,369
+28% +$1.94M 0.11% 179
2026
Q1
$4.76M Buy
1,158,895
+376,530
+48% +$1.82M 0.06% 265
2025
Q4
$5.2M Buy
782,365
+107,490
+16% +$728K 0.07% 246
2025
Q3
$4.14M Sell
674,875
-11,085
-2% -$86.4K 0.06% 273
2025
Q2
$6.32M Buy
+685,960
New +$7.02M 0.09% 203
2019
Q4
Sell
-1,200
Closed -$19K 720
2019
Q3
$19K Buy
+1,200
New +$19.7K ﹤0.01% 701

Other funds holding EOLS

Pinnacle Associates's EOLS Position: Q2 2026 in Review

Pinnacle Associates increased its Evolus (EOLS) stake by 28% in Q2 2026, buying an estimated $1.94M and bringing the position to 1,487,264 shares worth $10.3M. The position accounts for 0.11% of the portfolio, ranked #179.

Pinnacle Associates first reported a position in EOLS in Q3 2019 and has held it in 6 quarters since. 158 funds tracked by Wall St. Rank hold EOLS as of Q2 2026.

  • Pinnacle Associates held 1,487,264 shares of Evolus worth $10.3M as of Q2 2026.
  • Pinnacle Associates bought 328,369 Evolus shares in Q2 2026, an estimated $1.94M.
  • Evolus made up 0.11% of Pinnacle Associates's portfolio in Q2 2026, its #179 holding.
  • Pinnacle Associates first reported a position in Evolus in Q3 2019 and has held it in 6 quarters since.
  • 158 funds tracked by Wall St. Rank held Evolus as of Q2 2026.

Based on Pinnacle Associates's 13F filing for Q2 2026, filed 3 Aug 2026.